2024
DOI: 10.1038/s41398-024-03208-z
|View full text |Cite
|
Sign up to set email alerts
|

The role of gut microbiota and metabolomic pathways in modulating the efficacy of SSRIs for major depressive disorder

Ying Jiang,
Yucai Qu,
Lingyi Shi
et al.

Abstract: This study aims to explore the mechanism by which gut microbiota influences the antidepressant effects of serotonin reuptake inhibitors (SSRIs) through metabolic pathways. A total of 126 patients were analyzed for their gut microbiota and metabolomics. Patients received SSRI treatment and were categorized into responder and non-responder groups based on changes in their Hamilton Depression Rating Scale (HAMD-17) scores before and after treatment. The association between gut microbiota composition and the effic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 53 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?